Works matching DE "TROGLITAZONE"
Results: 49
Use and Abuse of "Historical Experts" in Toxic Tort Cases.
- Published in:
- Defense Counsel Journal, 2015, v. 82, n. 3, p. 321
- By:
- Publication type:
- Article
An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.
- Published in:
- Toxicological Sciences, 2018, v. 161, n. 2, p. 412, doi. 10.1093/toxsci/kfx219
- By:
- Publication type:
- Article
Fenretinide, Troglitazone, and Elmiron Add to Weight of Evidence Support for Hemangiosarcoma Mode-of-Action From Studies in Mice.
- Published in:
- Toxicological Sciences, 2018, v. 161, n. 1, p. 58, doi. 10.1093/toxsci/kfx195
- By:
- Publication type:
- Article
Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury.
- Published in:
- Toxicological Sciences, 2017, v. 158, n. 2, p. 347, doi. 10.1093/toxsci/kfx091
- By:
- Publication type:
- Article
3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies.
- Published in:
- Toxicological Sciences, 2013, v. 133, n. 1, p. 67, doi. 10.1093/toxsci/kft021
- By:
- Publication type:
- Article
Rosiglitazone attenuates the severity of hyperlipidemic severe acute pancreatitis in rats.
- Published in:
- Experimental & Therapeutic Medicine, 2013, v. 6, n. 4, p. 989, doi. 10.3892/etm.2013.1255
- By:
- Publication type:
- Article
Cell cycle synchronisation using thiazolidinediones affects cellular glucose metabolism and enhances the therapeutic effect of 2-deoxyglucose in colon cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-61661-4
- By:
- Publication type:
- Article
Simvastatin inhibited oxLDL-induced proatherogenic effects through calpain-1-PPARγ-CD36 pathway.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2016, v. 94, n. 12, p. 1336, doi. 10.1139/cjpp-2016-0295
- By:
- Publication type:
- Article
Differential Effect of Troglitazone on the Human Bile Acid Transporters, MRP2 and BSEP, in the PXB Hepatic Chimeric Mouse.
- Published in:
- Toxicologic Pathology, 2012, v. 40, n. 8, p. 1106, doi. 10.1177/0192623312447542
- By:
- Publication type:
- Article
Characterization of a novel murine preadipocyte line, AP-18, isolated from subcutaneous tissue: analysis of adipocyte-related gene expressions.
- Published in:
- Cell Biology International, 2010, v. 34, n. 3, p. 293, doi. 10.1042/CBI20090063
- By:
- Publication type:
- Article
Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Assessing immune hepatotoxicity of troglitazone with a versatile liver-immune-microphysiological-system.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1335836
- By:
- Publication type:
- Article
Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1378371
- By:
- Publication type:
- Article
Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 1211, doi. 10.2147/OTT.S79899
- By:
- Publication type:
- Article
Troglitazone metabolism and transporter effects in chimeric mice: a comparison between chimeric humanized and chimeric murinized FRG mice.
- Published in:
- Xenobiotica, 2014, v. 44, n. 2, p. 186, doi. 10.3109/00498254.2013.879237
- By:
- Publication type:
- Article
Endogenous and xenobiotic metabolite profiling of liver extracts from SCID and chimeric humanized mice following repeated oral administration of troglitazone.
- Published in:
- Xenobiotica, 2014, v. 44, n. 2, p. 174, doi. 10.3109/00498254.2013.867463
- By:
- Publication type:
- Article
Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized livers.
- Published in:
- Xenobiotica, 2012, v. 42, n. 6, p. 503, doi. 10.3109/00498254.2011.640716
- By:
- Publication type:
- Article
Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB.
- Published in:
- Journal of Inflammation, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12950-014-0044-1
- By:
- Publication type:
- Article
Troglitazone suppresses glutamine metabolism through a PPAR-independent mechanism.
- Published in:
- Biological Chemistry, 2015, v. 396, n. 8, p. 937, doi. 10.1515/hsz-2014-0307
- By:
- Publication type:
- Article
Case studies: Weight gain in two troglitazone-treated patients with improved glycemic control.
- Published in:
- 1999
- By:
- Publication type:
- Case Study
Case study: Making the clinical diagnosis of type 2 diabetes based on family history.
- Published in:
- Clinical Diabetes, 1999, v. 17, n. 1, p. 31
- By:
- Publication type:
- Article
Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0118674
- By:
- Publication type:
- Article
New Treatments for Patients With Diabetes.
- Published in:
- Diabetes Spectrum, 1998, v. 11, n. 1, p. 18
- By:
- Publication type:
- Article
The Pharmacologic Management of Patients with Type II Diabetes Mellitus in the Era of New Oral Agents and Insulin Analogs.
- Published in:
- Diabetes Spectrum, 1996, v. 9, n. 4, p. 227
- By:
- Publication type:
- Article
SPECTRUM BEAT.
- Published in:
- Diabetes Spectrum, 1995, v. 8, n. 3, p. 180
- By:
- Publication type:
- Article
Troglitazone inhibits the migration and invasion of PC‑3 human prostate cancer cells by upregulating E‑cadherin and glutathione peroxidase 3.
- Published in:
- Oncology Letters, 2018, v. 16, n. 4, p. 5482, doi. 10.3892/ol.2018.9278
- By:
- Publication type:
- Article
The effect of Baicalin, a PPARy activator, on erythroid differentiation of CD133<sup>+</sup> cord blood hematopoietic stem cells.
- Published in:
- Scientific Journal of Iranian Blood Transfusion Organization, 2014, v. 11, n. 1, p. 12
- By:
- Publication type:
- Article
In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2017, v. 36, p. 1, doi. 10.1186/s13046-017-0557-6
- By:
- Publication type:
- Article
RED TAPE TIGHTROPE: REGULATING FINANCIAL CONFLICTS OF INTEREST IN FDA ADVISORY COMMITTEES.
- Published in:
- Washington University Law Review, 2014, v. 91, n. 6, p. 1591
- By:
- Publication type:
- Article
Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 5, p. 188, doi. 10.1038/cgt.2014.16
- By:
- Publication type:
- Article
THE EFFECT OF TROGLITAZONE ON C-REACTIVE PROTEIN IN INDIVIDUALS WITH PREDIABETES: DATA FROM THE DIABETES PREVENTION PROGRAM.
- Published in:
- Journal of the Mississippi Academy of Sciences, 2018, v. 62, n. 2 Supplement, p. 275
- By:
- Publication type:
- Article
Dynamic culture of human liver equivalents inside a micro-bioreactor for long-term substance testing.
- Published in:
- BMC Proceedings, 2013, p. 1, doi. 10.1186/1753-6561-7-S6-P72
- By:
- Publication type:
- Article
Assessment of troglitazone induced liver toxicity in a dynamically perfused two-organ Micro-Bioreactor system.
- Published in:
- BMC Proceedings, 2013, p. 1, doi. 10.1186/1753-6561-7-S6-P71
- By:
- Publication type:
- Article
Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Non-cancer to anti-cancer: investigation of human ether-a-go-go-related gene potassium channel inhibitors as potential therapeutics.
- Published in:
- Journal of the Egyptian National Cancer Institute, 2021, v. 33, n. 1, p. 1, doi. 10.1186/s43046-021-00091-3
- By:
- Publication type:
- Article
The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells.
- Published in:
- PPAR Research, 2012, p. 1, doi. 10.1155/2012/929052
- By:
- Publication type:
- Article
TGFβ1 Controls PPARγ Expression, Transcriptional Potential, and Activity, in Part, through Smad3 Signaling in Murine Lung Fibroblasts.
- Published in:
- PPAR Research, 2012, p. 1, doi. 10.1155/2012/375876
- By:
- Publication type:
- Article
XML-CIMT: Explainable Machine Learning (XML) Model for Predicting Chemical-Induced Mitochondrial Toxicity.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15655, doi. 10.3390/ijms232415655
- By:
- Publication type:
- Article
Phenyllactic Acid from Lactobacillus plantarum Promotes Adipogenic Activity in 3T3-L1 Adipocyte via Up-Regulation of PPAR-γ2.
- Published in:
- Molecules, 2015, v. 20, n. 8, p. 15359, doi. 10.3390/molecules200815359
- By:
- Publication type:
- Article
Sensitizing primary acute lymphoblastic leukemia to natural killer cell recognition by induction of NKG2D ligands.
- Published in:
- Leukemia & Lymphoma, 2013, v. 54, n. 1, p. 167, doi. 10.3109/10428194.2012.708026
- By:
- Publication type:
- Article
Mechanistic Insights into Side Effects of Troglitazone and Rosiglitazone Using a Novel Inverse Molecular Docking Protocol.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 3, p. 315, doi. 10.3390/pharmaceutics13030315
- By:
- Publication type:
- Article
Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway.
- Published in:
- Mediators of Inflammation, 2014, v. 2014, p. 1, doi. 10.1155/2014/726068
- By:
- Publication type:
- Article
Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85708-2
- By:
- Publication type:
- Article
Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy.
- Published in:
- Yonsei Medical Journal, 2016, v. 57, n. 6, p. 1494, doi. 10.3349/ymj.2016.57.6.1494
- By:
- Publication type:
- Article
The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitntriors.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03319-z
- By:
- Publication type:
- Article
9-<i>cis</i>-Retinoic Acid and Troglitazone Impacts Cellular Adhesion, Proliferation, and Integrin Expression in K562 Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0093005
- By:
- Publication type:
- Article
Troglitazone Attenuates TGF-β1-Induced EMT in Alveolar Epithelial Cells via a PPARγ-Independent Mechanism.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038827
- By:
- Publication type:
- Article
Systems Pharmacology Modeling Predicts Delayed Presentation and Species Differences in Bile Acid-Mediated Troglitazone Hepatotoxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 5, p. 589, doi. 10.1038/clpt.2014.158
- By:
- Publication type:
- Article